AbCellera Biologics annual net debt
2020
2021
2022
2023
2024
2025
AbCellera Biologics Net Debt Growth & History (ABCL)
AbCellera Biologics's net debt was $14.7M for fiscal 2025.
View full AbCellera Biologics company overviewAbCellera Biologics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.7M | $105.7M | — |
| 2024 | 2024-12-31 | −$91.0M | −$35.0M | — |
| 2023 | 2023-12-31 | −$55.9M | $248.3M | — |
| 2022 | 2022-12-31 | −$304.3M | $131.8M | — |
| 2021 | 2021-12-31 | −$436.1M | $153.5M | — |
| 2020 | 2020-12-31 | −$589.5M | — | — |
AbCellera Biologics quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $15.6M | −$34.1M | −68.67% |
| Q1 2026 | 2026-03-31 | $63.1M | $154.5M | — |
| Q4 2025 | 2025-12-31 | $14.7M | $105.7M | — |
| Q3 2025 | 2025-09-30 | $59.1M | $114.3M | — |
| Q2 2025 | 2025-06-30 | $49.6M | $125.9M | — |
| Q1 2025 | 2025-03-31 | −$91.4M | −$41.5M | — |
| Q4 2024 | 2024-12-31 | −$91.0M | −$35.0M | — |
| Q3 2024 | 2024-09-30 | −$55.2M | $36.4M | — |
| Q2 2024 | 2024-06-30 | −$76.3M | $19.5M | — |
| Q1 2024 | 2024-03-31 | −$50.0M | $59.9M | — |
| Q4 2023 | 2023-12-31 | −$55.9M | $248.3M | — |
| Q3 2023 | 2023-09-30 | −$91.7M | $204.2M | — |
| Q2 2023 | 2023-06-30 | −$95.7M | $658.1M | — |
| Q1 2023 | 2023-03-31 | −$109.9M | $395.6M | — |
| Q4 2022 | 2022-12-31 | −$304.3M | $131.8M | — |
| Q3 2022 | 2022-09-30 | −$295.9M | $191.8M | — |
| Q2 2022 | 2022-06-30 | −$753.8M | $5.5M | — |
| Q1 2022 | 2022-03-31 | −$505.4M | $161.8M | — |
| Q4 2021 | 2021-12-31 | −$436.1M | $153.5M | — |
| Q3 2021 | 2021-09-30 | −$487.6M | — | — |
| Q2 2021 | 2021-06-30 | −$759.3M | — | — |
| Q1 2021 | 2021-03-31 | −$667.3M | — | — |
| Q4 2020 | 2020-12-31 | −$589.5M | — | — |
AbCellera Biologics net debt trends
Over the last five fiscal years, AbCellera Biologics's net debt increased from −$589.5M to $14.7M, a change of $604.2M. The latest reported quarter, Q2 2026, shows $15.6M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AbCellera Biologics source filings ↗